Advertisement
Research Article| Volume 21, ISSUE 3, P513-548, September 2001

Clinicopathologic Aspects of Bacterial Agents

  • Cdr Gregory J. Martin
    Correspondence
    Address reprint requests to CDR Gregory J. Martin, MD, MC, USN, Infectious Diseases Service, National Naval Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889.
    Affiliations
    From the Infectious Diseases Service, National Naval Medical Center; Departments of Medicine and Preventive Medicine and Tropical Public Health, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    Search for articles by this author
  • Cdr Aileen M. Marty
    Affiliations
    Departments of Pathology and Emerging Infectious Diseases, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30021-0
Clinicopathologic Aspects of Bacterial Agents
Previous ArticleThe Laboratory Role in Diagnosis of Infections Transmitted by Arthropods
Next ArticleAgroterrorism, Biological Crimes, and Biowarfare Targeting Animal Agriculture: The Clinical, Pathologic, Diagnostic, and Epidemiologic Features of Some Important Animal Diseases
      This paper is only available as a PDF. To read, Please Download here.
      Bacteria were the first organisms recognized for their potential as agents of bioaggression and the possibility of their use by a terrorist or rogue nation is considered a significant threat. Five of the more likely agents (anthrax, plague, tularemia, Q fever, and brucellosis) are reviewed with emphasis on their epidemiology, clinical presentation, diagnosis, and pathology Particular emphasis is given to the presentation of the diseases as they may appear after use in a biowarfare scenario.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abramova F.A.
        • Grinberg L.M.
        • Yampolskaya O.V.
        • et al.
        Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
        Proc Natl Acad Sci U S A. 1993; 90: 2291-2294
        • Al-Harthi S.S.
        The morbidity and mortality patterns of Brucella endocarditis.
        Int J Cardiol. 1989; 25: 321-324
        • Alizad A.
        • Ayoub E.M.
        • Makki N.
        Intestinal anthrax in a two year old child.
        Pediatr Infect Dis J. 1995; 14: 394-395
        • Alsofrom D.J.
        • Mettler F.A.
        • Mann f.M.
        Radiographic manifestations of plague in New Mexico, 1975-1980: A review of 42 proved cases.
        Radiology. 1981; 139: 561-565
        • Ariza J.
        Brucellosis.
        Curr Opin Infect Dis. 1996; 9: 126-131
        • Arya L.S.
        • Saidali A.
        • Qureshi M.A.
        • et al.
        Anthrax in infants and children in Afghanistan.
        Indian J Pediatr. 1982; 49: 529-534
        • Baca O.G.
        • Paretsky D.
        Q fever and Coxiella burnetii: A model for host parasite interactions.
        Microbiol Rev. 1983; 47: 127-149
      8. Behrman R.E. Kliegman R.M. Arvin A.M. Nelson Textbook of Pediatrics. ed 15. WB Saunders, Philadelphia1996
        • Berbari E.F.
        • Cockerill F.R.
        • Steckelberg J.M.
        Infective endocarditis due to unusual or fastidious microrganisms.
        Mayo Clin Proc. 1997; 72: 532-542
        • Bhatnagar R.
        • Singh Y.
        • Leppla S.H.
        • et al.
        Calcium is required for the expression of anthrax lethal toxin activity in the macrophagelike cell line J774A.1.
        Infect Immunol. 1989; 57: 2107-2114
        • Brachman P.S.
        Anthrax.
        in: Hoeprich P.D. Fordan M.C. Ronald A.R. Infectious Disease. ed 5. Lippincott, Philadelphia1994: 1003-1008
        • Brouqui P.
        • Dupont H.T.
        • Drancourt M.
        • et al.
        Chronic Q fever: Ninety-two cases from France, including 27 cases without endocarditis.
        Arch Intern Med. 1993; 153: 642-648
        • Brubaker R.R.
        Factors promoting acute and chronic disease caused by Yersiniae.
        Clin Microbiol Rev. 1991; 4: 301-324
        • Butler T.
        Yersinia infections: Centennial of the discovery of the plague bacillus.
        Clin Infect Dis. 1994; 19: 655-663
        • Butler T.
        Yersinia species, including plague.
        in: Mandeli G.L. Bennett I.E. Dolin R. Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia2000: 2406-2414
        • Byrne W.R.
        Q fever.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologic Warfare. Office of the Surgeon General, US Army, Washington1997: 523-537
        • Caron F.
        • Meurice F.C.
        • Ingrand P.
        Acute Q fever pneumonia: A review of 80 hospitalized patients.
        Chest. 1998; 114: 808-813
        • Cavanaugh D.C.
        • Cadigan F.C.
        • Williams J.E.
        • et al.
        Plague.
        in: Ognibene A.J. Barrett O. General Medicine and Infectious Diseases, vol 2. Office of the Surgeon General, Washington1982: 167-196
        • Centers for Disease Control and Prevention
        Fatal human plague-Arizona and Colorado, 1996.
        MMWR Morb Mortal Wkly Rep. 1997; 46: 617-621
        • Centers for Disease Control and Prevention
        Prevention of plague.
        MMWR Morb Mortal Wkly Rep. 1996; 45: RR-14
        • Chomel B.B.
        • DeBess E.E.
        • Mangiamele D.M.
        • et al.
        Changing trends in the epidemiology of human brucellosis in California from 1973-1992: A shift toward foodborne transmisision.
        J Infect Dis. 1994; 170: 1216-1223
        • Colmenero J.D.
        • Reguera J.M.
        • Martos F.
        • et al.
        Complications associated with Brucella melitensis infection: A study of 530 cases.
        Medicine. 1996; 75: 195-211
        • Cornells G.R.
        Molecular and cell biology aspects of plague.
        Proc Natl Acad Sci U S A. 2000; 97: 8778-8783
        • Crook L.D.
        • Tempest B.
        Plague: A clinical review of 27 cases.
        Arch Intern Med. 1992; 152: 1253-1256
        • Crosby E.
        • Llosa L.
        • Quesada M.M.
        • et al.
        Hematologic changes in brucellosis.
        J Infect Dis. 1984; 150: 419-424
        • Cross J.T.
        • Penn R.L.
        Francisella tularensis (tularemia).
        in: Mandeli G.L. Bennett J.E. Dolin R. Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia2000: 2393-2402
        • Dolan S.A.
        • Dommaraju C.B.
        • DeGuzman G.B.
        Detection of Francisella tularensis in clinical specimens by use of polymerase chain reaction.
        Clin Infect Dis. 1998; 26: 764-765
        • Dupont H.T.
        • Raoult D.
        • Brouqui P.
        • et al.
        Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases.
        Am J Med. 1992; 93: 427-434
        • Edwards M.S.
        Anthrax.
        in: Feigin R.D. Cherry J.D. Textbook of Pediatric Infectious Disease. ed 4. WB Saunders, Philadelphia1998: 1176-1179
        • Eitzen E.M.
        Use of biological weapons.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologic Warfare. Office of the Surgeon General, US Army, Washington1997: 437-450
        • Evans M.E.
        • Friedlander A.M.
        Tularemia.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologic Warfare. Office of the Surgeon General, US Army, Washington1997: 503-512
        • Evans M.E.
        • Gregory D.W.
        • Schaffner W.
        • et al.
        Tularemia: A 30-year experience with 88 cases.
        Medicine. 1985; 64: 251-269
        • Farrar W.E.
        Anthrax: Virulence and vaccines.
        Ann Intern Med. 1994; 121: 379-380
        • Faul J.L.
        • Doyle R.L.
        • Kao P.N.
        • et al.
        Tick-borne pulmonary disease: Update on diagnosis and management.
        Chest. 1999; 116: 222-230
        • Franz D.R.
        • Jahrling P.B.
        • Friedlander A.M.
        • et al.
        Clinical recognition and management of patients exposed to biologic warfare agents.
        JAMA. 1997; 278: 399M11
        • Friedlander A.M.
        Anthrax.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologic Warfare. Office of the Surgeon General, US Army, Washington1997: 467-478
        • Friedlander A.M.
        Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
        J Biol Chem. 1986; 261: 7123-7126
        • Gage K.L.
        • Dennis D.T.
        • Orloski K.A.
        • et al.
        Cases of cat-associated human plague in the Western US: 1977-1998.
        Clin Infect Dis. 2000; 30: 893-901
        • Gazapo E.
        • Lahoz J.G.
        • Subiza J.L.
        • et al.
        Changes in IgM and IgG antibody concentrations in brucellosis over time: Importance for diagnosis and follow up.
        J Infect Dis. 1989; 159: 219-225
        • Gordon J.D.
        • MacKean A.S.
        • Marrie T.J.
        • et al.
        The radiographic features of epidemic and sporadic Q fever pneumonia.
        J Can Assoc Radiol. 1984; 35: 293-296
        • Gotuzzo E.
        • Carrillo C.
        • Guerra J.
        • et al.
        An evaluation of diagnostic methods for brucellosis: The value of bone marrow culture.
        J Infect Dis. 1986; 153: 122-125
        • Guo H.R.
        • Gilman R.
        • Waag D.M.
        Prevalence of Coxiella burnetii infections among North Dakota sheep producers.
        J Occup Environ Med. 1998; 40: 999-1006
        • Hahon N.
        • Zimmerman W.D.
        Intracellular survival of viral and rickettsial agents in acetone at -60°C.
        Appl Microbiol. 1969; 17: 775-776
        • Hail A.S.
        • Rossi C.A.
        • Ludwig G.V.
        • et al.
        Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure.
        Mil Med. 1999; 164: 833-837
        • Harrison L.H.
        • Ezzell J.W.
        • Abshire T.G.
        • et al.
        Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
        J Infect Dis. 1989; 160: 706-710
        • Hoover D.L.
        • Friedlander A.M.
        Brucellosis.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologie Warfare. Office of the Surgeon General, US Army, Washington1997: 513-521
        • Humphries R.C.
        • Hinrichs D.J.
        Role of antibody in Coxiella burnetii infection.
        Infect Immun. 1981; 31: 641-645
        • Ibrahim A.I.A.
        • Awad R.
        • Shetty S.D.
        • et al.
        Genito-urinary complications of brucellosis.
        Br J Urol. 1988; 61: 294-298
        • Ibrahim K.H.
        • Brown G.
        • Wright D.H.
        • et al.
        Bacillus anthracis: Medical issues of biologic warfare.
        Pharmacotherapy. 1999; 19: 690-701
        • Inglesby T.V.
        • Dennis D.T.
        • Henderson D.A.
        • et al.
        Plague as a biologic weapon: Medical and public health management.
        JAMA. 2000; 283: 2281-2290
        • Jackson P.J.
        • Hugh-Jones M.E.
        • Adair D.M.
        • et al.
        PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multiple Bacillus anthracis strains in different victims.
        Proc Natl Acad Sci U S A. 1998; 95: 1224-1229
        • Jacobs F.
        • Abramowicz D.
        • Vereerstraeten P.
        • et al.
        Brucella endocarditis: The role of combined medical and surgical treatment.
        Rev Infect Dis. 1990; 12: 740-744
        • Jacobs R.F.
        • Condrey Y.M.
        • Yamauchi T.
        Tularemia in adults and children: A changing presentation.
        Pediatrics. 1985; 76: 818-822
      54. Katz S.L. Gershon A.A. Hotez P.J. Krugman’s Infectious Diseases of Children. ed 10. Mosby, St. Louis1998
        • Kaufmann A.F.
        • Meitzer M.I.
        • Schmid G.P.
        The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable?.
        Emerg Infect Dis. 1997; 3: 83-94
        • Kolman S.
        • Maayan M.C.
        • Gotesman G.
        • et al.
        Comparison of BACTEC and lysis centrifugation methods for recovering Brucella species from clinical specimens.
        Eur J Clin Microbiol Infect Dis. 1991; 10: 647-648
        • Kwong K.L.
        • Que T.L.
        • Wong S.N.
        • et al.
        Fatal meningoencephalitis due to Bacillus anthracis.
        J Pediatr Child Health. 1997; 33: 539-541
        • LaForce F.M.
        Anthrax.
        Clin Infect Dis. 1994; 19: 1009-1014
        • Lalitha M.K.
        • Thomas M.K.
        Penicillin resistance in Bacillus anthracis.
        Lancet. 1997; 349: 1522
        • Langley J.M.
        • Marrie T.J.
        • Covert A.
        • et al.
        Poker players’ pneumonia: An urban outbreak of Q fever following exposure to a parturient cat.
        N Engl J Med. 1988; 319: 354-356
        • Lew D.P.
        Bacillus anthracis (anthrax).
        in: Mandeli G.L. Bennett J.E. Dolin R. Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia2000: 2215-2226
        • Li J.S.
        • Sexton D.J.
        • Mick N.
        • et al.
        Proposed modifications to the Duke criteria for the diagnosis of infective endoocarditis.
        Clin Infect Dis. 2000; 30: 633-638
        • Marrie T.J.
        • Raoult D.
        Coxiella.
        in: Murray P.R. Baron E.J. Pfaller M.A. Manual of Clinical Microbiology. ed 7. American Society for Microbiology, ASM Press, Washington1999: 815-820
        • McCaul T.F.
        • Williams J.C.
        Developmental cycle of Coxiella burnetii: Structure and morphogenesis of vegetative and sporogenic differentiations.
        J Bacteriol. 1981; 147: 1063-1076
        • McEvedy C.
        The bubonic plague.
        Sci Am. 1988; 258: 118-123
        • McGovern T.W.
        • Christopher G.W.
        • Eitzen E.M.
        Cutaneous manifestations of biologic warfare and related threat agents.
        Arch Dermatol. 1999; 135: 311-322
        • McGovern T.W.
        • Friedlander A.M.
        Plague.
        in: Sidell F.R. Takafuji E.T. Franz D.R. Medical Aspects of Chemical and Biologic Warfare. Office of the Surgeon General, US Army, Washington1997: 479-502
        • Meselson M.
        • Guillemin J.
        • Hugh-Jones M.
        • et al.
        The Sverdlovsk anthrax outbreak of 1979.
        Science. 1994; 266: 1202-1208
        • Michaux-Charachon S.
        • Bourg G.
        • Jumas-Bilak E.
        • et al.
        Genome structure and phylogeny in the genus Brucella.
        J Bacteriol. 1997; 179: 3244-3249
        • Miller R.P.
        • Bates J.H.
        Pleuropulmonary tularemia: A review of 29 patients.
        Am Rev Respir Dis. 1969; 99: 31-41
        • Mousa A.R.
        • Muhtaseb S.A.
        • Almudallal D.S.
        • et al.
        Osteoarticular complications of brucellosis: A study of 169 cases.
        Rev Infect Dis. 1987; 9: 531-543
        • O’Brien J.
        • Friedlander A.
        • Dreier T.
        • et al.
        Effects of anthrax toxin components on human neutrophils.
        Infect Immun. 1985; 47: 306-310
        • Ohara Y.
        Arthropod-borne tularemia in Japan: Clinical analysis of 1374 cases observed between 1924 and 1996.
        J Med Entomol. 1998; 35: 471-473
        • Overholt E.L.
        • Tigertt W.D.
        Roentgenographic manifestations of pulmonary tularemia.
        Radiology. 1960; 74: 758-764
        • Ozkaya E.
        • Kirimi E.
        • Berktas M.
        • et al.
        Bacillus anthracis sepsis in a newborn.
        Pediatr Infect Dis J. 2000; 19: 487-488
        • Patel P.J.
        • Al-Suhaibani H.
        • Al-Aska A.K.
        • et al.
        The chest radiograph in brucellosis.
        Clin Radiol. 1998; 39: 39-41
        • Peacock M.G.
        • Philip R.N.
        • Williams J.C.
        • et al.
        Serologic evaluation of Q fever in humans: Enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis.
        Infect Immun. 1983; 41: 1089-1098
        • Penn C.C.
        Anthrax pneumonia.
        Semin Respir Infect. 1997; 12: 28-30
        • Penn R.L.
        • Kinasewetz G.T.
        Factors associated with a poor outcome in tularemia.
        Arch Intern Med. 1987; 147: 265-268
        • Perry R.D.
        • Fetherston J.D.
        Yersinia pestis: Etiologic agent of plague.
        Clin Microbiol Rev. 1997; 10: 35-66
        • Petrella R.
        • Young E.J.
        Acute brucella ileitis.
        Am J Gastroenterol. 1988; 83: 80-82
        • Pile J.C.
        • Malone J.D.
        • Eitzen E.M.
        • et al.
        Anthrax as a potential biological warfare agent.
        Arch Intern Med. 1998; 158: 429-434
        • Provenza M.J.
        • Klotz S.A.
        • Penn R.L.
        Isolation of Francisella tularensis from blood.
        J Clin Microbiol. 1986; 24: 453-455
        • Pullen R.L.
        • Stuart B.M.
        Tularemia: Analysis of 225 cases.
        JAMA. 1945; 129: 495-500
        • Quan S.F.
        • McManus A.G.
        • von Fintel H.
        Infectivity of tularemia applied to intact skin and ingestion in drinking water.
        Science. 1956; 123: 942-943
        • Rabinowitz L.O.
        • Zaim M.T.
        A clinicopathologic approach to granulomatous dermatoses.
        J Am Acad Dermatol. 1996; 35: 588-600
        • Sawyer L.A.
        • Fishbein D.B.
        • McDade J.E.
        Q fever: Current concepts.
        Rev Infect Dis. 1987; 9: 935-946
        • Shafazand S.
        • Doyle R.
        • Ruoss S.
        • et al.
        Inhalational anthrax: Epidemiology, diagnosis and management.
        Chest. 1999; 116: 1369-1376
        • Sirard J.C.
        • Mock M.
        • Fouet A.
        The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature.
        J Bacteriol. 1994; 176: 5188-5192
        • Smego R.A.
        • Castiglia M.
        • Asperilla M.O.
        Lymphocutaneous syndrome: A review of non-sporothrix causes.
        Medicine. 1999; 78: 38-63
        • Smego R.A.
        • Gebrian B.
        • Desmangels G.
        Cutaneous manifestations of anthrax in rural Haiti.
        Clin Infect Dis. 1998; 26: 97-102
        • Smith D.L.
        • Wellings R.
        • Walker C.
        • et al.
        The chest x-ray in Q fever: A report on 69 cases from the 1989 West Midlands outbreak.
        Br J Radiol. 1991; 64: 1101-1108
        • Smith H.
        • Keppie J.
        Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by Bacillus anthracis.
        Nature. 1954; 173: 869-870
        • Smits H.L.
        • Basahi M.A.
        • Diaz R.
        • et al.
        Development and evaluation of a rapid dipstick assay for serodiagnosis of acute human brucellosis.
        J Clin Microbiol. 1999; 37: 4179-4182
        • Sotiris M.
        • Ioannis K.
        Anthrax in children: A long forgotten, potentially fatal infection.
        Scand J Infect Dis. 1979; 11: 203-206
        • Speck R.S.
        • Wolochow H.
        Studies on the experimental epidemiology of respiratory infections VIII: Experimental pneumonic plague in Macaccus rhesus.
        J Infect Dis. 1957; 100: 58-68
        • Syrjälä H.
        • Koskela P.
        • Ripatti T.
        • et al.
        Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the diseases.
        J Infect Dis. 1986; 153: 142-145
        • Tabatabaie P.
        • Syadati A.
        Bacillus anthracis as a cause of bacterial meningitis.
        Pediatr Infect Dis J. 1993; 12: 1035-1036
        • Tamvik A.
        • Sandstrom G.
        • Sjostedt A.
        Infrequent manifestations of tularaemia in Sweden.
        Scand J Infect Dis. 1997; 29: 443-446
        • Taylor J.P.
        • Istre G.R.
        • McChesney T.C.
        • et al.
        Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987.
        Am J Epidemiol. 1991; 133: 1032-1038
        • Turnbull P.C.
        Definitive identification of Bacillus anthracis: A review.
        J Appl Microbiol. 1999; 87: 237-240
        • Turnbull P.C.B.
        • Kramer J.M.
        Bacillus.
        in: Murray P.R. Baron E.J. Pfaller M.A. Manual of Clinical Microbiology. ed 6. American Society for Microbiology, ASM Press, Washington1995: 296-303
        • Uhaa I.J.
        • Fishbein D.B.
        • Olson J.G.
        • et al.
        Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever.
        J Clin Microbiol. 1994; 32: 1560-1565
        • Vizitiu O.
        • Badescu D.
        • Balaci L.
        • et al.
        Biological products and laboratory reagents dehydrated by a rapid direct vacuum desiccation method. VI. Studies of the preservation of microbial strains (C. burnetii, Chlamydia psittaci, Mycoplasma pneumoniae) and a laboratory reagent (para-nitrophenyl phosphate) by vacuum desiccation.
        Bacteriol Virusol Parazitol Epidemiol. 1992; 37: 53-55
        • Walker D.H.
        • Yampolska L.
        • Grinberg L.M.
        Death at Sverdlovsk: What have we learned?.
        Am J Pathol. 1994; 144: 1135-1141
        • Welty T.K.
        • Grabman J.
        • Kompare E.
        • et al.
        Nineteen cases of plague in Arizona: A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy.
        West J Med. 1985; 142: 641-646
        • Westerman E.L.
        • McDonald H.
        Tularemia pneumonia mimicking Legionnaire’s disease: Isolation of organisms on CYE agar and successful treatment with erythromycin.
        South Med J. 1983; 76: 1169-1171
        • Wong J.D.
        • Shapiro D.S.
        Francisella.
        in: Murray P.R. Baron E.J. Pfaller M.A. Manual of Clinical Microbiology. ed 7. American Society for Microbiology, ASM Press, Washington1999: 647-651
        • World Health Organization
        Chemical and Biological Weapons: The Hazard to Health.
        WHO Chronicle. 1979; 24: 99-108
        • Young E.J.
        An overview of human brucellosis.
        Clin Infect Dis. 1995; 21: 283-290
        • Young E.J.
        Brucella species.
        in: Mandeli G.L. Bennett J.E. Dolin R. Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia2000: 2386-2393
        • Young E.J.
        Serologic diagnosis of human brucellosis: Analysis of 214 cases by agglutination tests and review of the literature.
        Rev Infect Dis. 1991; 13: 359-372
        • Young E.J.
        • Borchert M.
        • Kretzer F.L.
        • et al.
        Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes.
        J Infect Dis. 1985; 151: 682-690
        • Young E.J.
        • Suvannoparrat U.
        Brucellosis outbreak attributed to ingestion of unpasteurized goat cheese.
        Arch Intern Med. 1975; 135: 240-243
        • Young L.S.
        • Bicknell D.S.
        • Archer B.G.
        Tularemia epidemic: Vermont 1968: Forty seven cases linked to contact with muskrats.
        N Engl J Med. 1969; 280: 1253-1260

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30021-0

      Copyright

      © 2001 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX